GlassScriptPhysician profile
Dodie Deming
NPI 1275179228
$1,476.44
in general payments reported to CMS, 2019-2025
9 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.07 · 2022: $455 · 2023: $194 · 2024: $494 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $919 · Gift: $42.50 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $918.98 |
| Gift | $42.50 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $431.73 | 2022-2024 | Mounjaro, Trulicity, Zepbound |
| Novo Nordisk INC | $264.51 | 2022-2023 | |
| Beta Bionics, INC. | $227.55 | 2023-2024 | Ilet Bionic Pancreas |
| Abbott Laboratories | $175.21 | 2024-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $153.68 | 2024-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.39 | 2023-2024 | Jardiance |
| Mannkind Corporation | $85.00 | 2024-2025 | |
| Insulet Corporation | $17.07 | 2021 | |
| Cequr Corporation | $10.30 | 2023 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dodie Deming listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.